Granules Establishes Prince William County, Virginia, Pharmaceutical Packaging Complex
12/02/2022
The new facility will be part of the company’s Consumer Health division and will return previously outsourced services in-house. Granules will lease 79,000-square-feet of the Parkway 66 property at 7413 Cushing Road in Manassas and build out packaging lines and clean rooms to package and ship pharmaceuticals.
“The addition of a U.S. packaging facility will result in Granules being among the few pharmaceutical companies to be vertically integrated from API to packaging, which will bolster the robustness of Granules’ supply chain while also enabling the company to react even faster to consumers’ growing needs for pharmaceutical products,” said Dr. Krishna Prasad Chigurupati, Founder and Managing Director. “The company chose Virginia because of Prince William County’s responsiveness which allowed Granules faster access to commercialization. In addition, Prince William offers a dynamic and diverse workforce that is eager to work along with the site’s proximity to several major seaports. Granules also chose to expand within Virginia to leverage its existing manufacturing footprint and workforce.”
The Virginia Economic Development Partnership (VEDP) worked with Prince William County to secure the investment. The Governor’s office approved a $200,000 grant from the Commonwealth’s Opportunity Fund to assist Prince William County with the project.
“When a global company like Granules India establishes a second Virginia operation, it reinforces that our business-friendly climate, collaborative environment, and skilled workforce,” noted Secretary of Commerce and Trade Caren Merrick. “The Commonwealth’s pharmaceutical sector has gained significant momentum in recent years, and we thank Granules for continuing our success in this booming industry.”
Founded in 1984 and headquartered in Hyderabad, India, Granules India serves leading brand and generics companies in over 75 countries with eight manufacturing facilities around the world. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages, and its products include common consumer drugs such as acetaminophen, ibuprofen and guaifenesin (key ingredient in Mucinex). Granules employs 130 at a pharmaceutical R&D and manufacturing facility in Fairfax County.
Project Announcements
The Shaw Group Expands Walker, Louisiana, Operations
02/04/2026
Italy-Based Huwell US Plans Cherokee County, South Carolina, Operations
02/04/2026
Eli Lilly and Company Plans Lehigh Valley, Pennsylvania, Manufacturing Operations
02/02/2026
Hadrian Establishes Mesa, Arizona, Manufacturing Operations
02/02/2026
Canada-Based Cyclic Materials Plans McBee, South Carolina, Operations
02/02/2026
PC3 Health Plans Jeffersonville, Indiana, Operations
02/02/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025